1 Day TOX 6.12% DJIA 0.08% Russell 2K -0.56% Business/Consumer Services -1.77% ...
GLP-tox study reinforces favorable safety profile of Tiprelestat Phase II Study in Pulmonary Arterial Hypertension (PAH) to be initiated by Stanford University in mid-2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback